Bundle of Coated Devices to Reduce Nosocomial Infections in the Intensive Care Unit. CRITIC Pilot Randomized Controlled Trial

Autor: Fernando G. Zampieri, Neymar Elias de Oliveira, Antonio Paulo Nassar, Airton Leonardo de Oliveira Manoel, Cintia Grion, Fábio H. Lacerda, Israel Maia, Marlus Thompson, Thiago Simões Giancursi, Priscilla de Aquino Martins, Thiago Lisboa, Tamiris Abait, Lucas P. Damiani, Flávia R. Machado, Alexandre B. Cavalcanti, Livia Pereira Miranda Prado, Ricardo Costa Nuevo, Silvana Soares dos Santos, Eliana Viera do Nascimento Martins, Cássio Zandonai, Thaís Fonseca e Gobbo, Érica Juliane da Silva Pereira, Christiane Tokiko Marçal Uka, Maria Aparecida de Souza

Publikováno v: Zampieri, F G, Oliveira, N E D, Nassar, A P, De Oliveira Manoel, A L, Grion, C, Lacerda, F A H, Maia, I, Thompson, M, Giancursi, T S, Martins, P D A, Lisboa, T, Abait, T, Damiani, L P, MacHado, F A R, Cavalcanti, A B & for the BRICNet 2020, ' Bundle of Coated Devices to Reduce Nosocomial Infections in the Intensive Care Unit. CRITIC Pilot Randomized Controlled Trial ', Annals of the American Thoracic Society, vol. 17, no. 10, pp. 1257-1263 . https://doi.org/10.1513/AnnalsATS.202003-206OC

Rationale: Coated devices may reduce biofilm formation and reduce the occurrence of device-related infections in critically ill patients. A bundle of coated devices (an endotracheal tube [ETT], central venous catheter [CVC], and urinary catheter [UC]

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a46a19fd22eec4ef7955f65568863fa
https://doi.org/10.1513/annalsats.202003-206oc

Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial

Autor: Estêvão Lanna Figueiredo, Dario Rafael Abregu Diaz, Alexandre Biasi Cavalcanti, Aline de Oliveira Twardowsky, Alexandre de Matos Soeiro, Marianna Deway Andrade Dracoulakis, Renato D. Lopes, Vinicius Santana Nunes, Anne Cristine Silva Fernandes, Júlia de Aveiro Morata, Mauro E. Hernandes, Gilson Soares Feitosa-Filho, Manoel Fernandes Canesin, Lilia Nigro Maia, Vicente C.S. Dantas, Viviane C Veiga, Ana Thereza Rocha, Otavio Gebara, Remo H.M. Furtado, Lilian Mazza Barbosa, Sueli V Santos, Leonardo Meira de Faria, Lorena Souza Viana, Aryadne Lyrio de Oliveira, Flávia Ribeiro Machado, Idelzuíta Leandro Liporace, Diego Aparecido Rios Queiroz, Fernando Carvalho Neuenschwander, Regis Goulart Rosa, Mariana Silveira de Alcântara Chaud, Livia Maria Garcia Melro, Ariane Vieira Scarlatelli Macedo, Patrícia O. Guimarães, Priscilla de Aquino Martins, John H. Alexander, Eduardo Ramacciotti, Luiz Eduardo Fonteles Ritt, Alvaro Avezum, Luciano Cesar Pontes Azevedo, Lucas Tramujas, Luciana Armaganijan, Rodolfo Godinho Souza Dourado Lima, Bruna Bronhara, Germano Emílio Conceição-Souza, Marcelo Basso Gazzana, Pedro Gabriel Melo de Barros e Silva, Otavio Berwanger, Lucas P. Damiani

Publikováno v: Lancet (London, England)
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP

Made available in DSpace on 2022-04-29T08:29:34Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-06-12 Background: COVID-19 is associated with a prothrombotic state leading to adverse clinical outcomes. Whether therapeutic anticoagulation impro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bfabd0d574887435b7d90aaad9e1ccc
https://pubmed.ncbi.nlm.nih.gov/34627488